EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 370 filers reported holding EXELIXIS INC in Q3 2020. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $215,000 | +0.5% | 10,181 | -13.3% | 0.01% | 0.0% |
| Q2 2021 | $214,000 | -18.9% | 11,747 | +0.4% | 0.01% | -33.3% |
| Q1 2021 | $264,000 | +12.3% | 11,700 | 0.0% | 0.02% | -28.6% |
| Q4 2020 | $235,000 | -13.3% | 11,700 | +5.6% | 0.02% | -19.2% |
| Q3 2020 | $271,000 | +0.7% | 11,080 | -2.4% | 0.03% | +4.0% |
| Q2 2020 | $269,000 | -58.7% | 11,348 | -62.8% | 0.02% | -62.1% |
| Q2 2019 | $652,000 | -23.3% | 30,514 | -14.5% | 0.07% | -27.5% |
| Q1 2019 | $850,000 | +31.6% | 35,704 | +8.7% | 0.09% | +9.6% |
| Q4 2018 | $646,000 | -20.9% | 32,850 | -28.7% | 0.08% | -10.8% |
| Q3 2018 | $817,000 | -5.3% | 46,101 | +14.9% | 0.09% | -13.1% |
| Q2 2018 | $863,000 | +174.0% | 40,108 | +182.2% | 0.11% | +161.0% |
| Q1 2018 | $315,000 | +1650.0% | 14,215 | +23.4% | 0.04% | +1266.7% |
| Q3 2014 | $18,000 | – | 11,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |